ACB
Aurora Cannabis
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and New York Stock Exchange as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. Aurora is the second largest cannabis company in the world by market capitalization, after Canopy Growth Corporation. The company began trading on the NYSE on October 23rd, 2018 using the ticker ACB.After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO.
Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 513.91M; Volume: 14.12M; AvgVol 3m: 4.68M; Beta: –;
Cost estimate:
P/E: –; EPS: –; EPS growth quarter/prev quarter: ;
EPS growth this year: ; EPS growth past 5 years: ;
EPS ttm: 0.22;
P/S: ; P/B: 1.31; P/Cashflow: ; P/FCF: ;
Sales: 6.73M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 2.90%; Insider Transactions:0.00%;
Institutional Ownership: 12.27%; Institutional Transactions: ;
Data update: 07/10/2020.